BSECompany Update28 Sept 2026 · 28 Sept 2026, 12:00 pm
Disclosure pursuant to Regulation 30 read with Schedule III of SEBI Listing Regulations
Torrent Pharmaceuticals Ltd · 500420
✦ AI SummaryExpansion
Torrent Pharmaceuticals Ltd has announced an amendment to the Share Subscription and Shareholders' Agreement to increase its investment in Torrent Urja 27 Private Limited, a wholly-owned subsidiary, to enhance the share of renewable power sources in the company's operations.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Attachments (1)
📄pdf
Download →
01c25205-0260-4c96-8d3e-663210767b70.pdf
View document text
28th September, 2026
The Dy. General Manager (Listing Dept.) The Manager – Listing Dept.,
BSE Limited, National Stock Exchange of India Limited
Corporate Relationship Dept., Exchange Plaza, 5th Floor,
1st Floor, New Trading Ring, Plot No. C/1, G. Block,
P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E),
Mumbai - 400 001 Mumbai - 400 051
(BSE Scrip Code: 500420) (NSE Symbol: TORNTPHARM)
Dear Sir/ Madam,
Sub.: Disclosure pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)
====================================================================
We refer to our earlier intimation dated 10th September, 2025 with respect to entering into the Share
Subscription and Shareholders’ Agreement (“SSSA”) to subscribe to 26% equity shares of Torrent
Urja 27 Private Limited (“Torrent Urja”) for setting up captive hybrid (Solar + Wind) power project in
the State of Gujarat to enhance the share of renewable power sources in the operation of the Company.
In furtherance to the above, we would like to inform you that the Amendment Agreement to SSSA
dated 28th September, 2026 has been executed to enhance the investment of the Company in Torrent
Urja from INR 7,91,93,400 to INR 11,87,90,100 as a result of increase in the project capacity.
The relevant details as required under Regulation 30 of the Listing Regulations read with SEBI master
circular dated 30th January, 2026, bearing reference no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026
(“Master Circular”) with respect to the Proposed Transaction is set out in Annexure A.
You are requested to take the above on record.
Thanking you,
Yours sincerely,
For TORRENT PHARMACEUTICALS LIMITED
CHINTAN M. TRIVEDI
COMPANY SECRETARY
Encl : As above
Email – investorservices@torrentpharma.com
Annexure A
The details regarding the Proposed Transaction as required under Regulation 30 and Schedule III
of the Listing Regulations, read with the Master Circular, are as under:
Sr. Particulars Details
1. Name of the target entity, details in Name of Target entity: Torrent Urja 27 Private
brief such as size, turnover etc. Limited (“Torrent Urja”).
Brief Details: Torrent Urja, currently a wholly
owned subsidiary of Torrent Green Energy Private
Limited, is a special purpose vehicle formed for
setting up captive power project in Gujarat.
Turnover: Nil as on 31st March, 2026
2. Whether the acquisition would fall Yes. Torrent Urja is an Associate Company of the
within related party transaction(s) and Company and step down Subsidiary of Company’s
whether the promoter/ promoter holding Company. The Transaction is being
group/ group companies have any carried out at arm’s length basis.
interest in the entity being acquired? If
yes, nature of interest and details
thereof and whether the same is done
at “arm’s length”
3. Industry to which the entity being Generation and transmission of hybrid energy,
acquired belongs consisting of wind, solar and other sources of
renewable energy.
4. Objects and impact of acquisition In order to enhance the share of renewable power
(including but not limited to, sources in the operation of the Company and to
disclosure of reasons for acquisition of comply with regulatory requirement for being a
target entity, if its business is outside captive user under Indian electricity laws, the
the main line of business of the listed Company will enhance the investment in Torrent
entity) Urja to acquire 26% of stake in Torrent Urja.
5. Brief details of any governmental or Not applicable
regulatory approvals required for the
acquisition
6. Indicative time period for completion 18 to 21 months
of the acquisition
Email – investorservices@torrentpharma.com
Sr. Particulars Details
7. Consideration - whether cash Cash Consideration
consideration or share swap or any
other form and details of the same
8. Cost of acquisition and/or the price at INR 11,87,90,100 (Rupees Eleven Crores Eighty
which the shares are acquired Seven Lakhs Ninety Thousand and One Hundred
Only) – 1,18,79,010 Class A Equity Shares of Face
Value of Rs. 10/- each.
9 Percentage of shareholding/ control 26%
acquired and/ or number of shares
acquired
10 Brief background about the entity Brief Background:
acquired in terms of products/line of
business acquired, date of Torrent Urja is incorporated in India and
incorporation, history of last 3 years registered with the Registrar of Companies,
turnover, country in which the Gujarat at Ahmedabad on 06-Aug-24, and is yet
acquired entity has presence and any to commence its business operations.
other significant information (in brief)
Email – investorservices@torrentpharma.com